Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002712501 | SCV003554272 | uncertain significance | Inborn genetic diseases | 2021-03-02 | criteria provided, single submitter | clinical testing | The c.260T>C (p.L87P) alteration is located in exon 2 (coding exon 2) of the CHKB gene. This alteration results from a T to C substitution at nucleotide position 260, causing the leucine (L) at amino acid position 87 to be replaced by a proline (P). The in silico prediction for the p.L87P alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Next Generation Genetic Polyclinic | RCV003126275 | SCV003801421 | uncertain significance | Megaconial type congenital muscular dystrophy | 2023-02-13 | no assertion criteria provided | clinical testing |